Indacaterol/glycopyrronium ( IND/GLY ) is a once-daily inhaled fixed-dose combination of indacaterol ( IND ) , a long-acting 2-adrenergic agonist ( LABA ) , and glycopyrronium ( GLY ) , a long-acting muscarinic antagonist ( LAMA ) for use as maintenance treatment to relieve symptoms of chronic obstructive pulmonary disease ( COPD ) in adults .